{"pageContent": "Objective: To assess clinical safety (primary) and efficacy (secondary) of histotripsy for treatment of symptomatic benign prostatic enlargement in a first-in human study.", "metaData": {"source": "[First-line therapy for low-risk prostate cancer: prospective phase II study of focal therapy (hemiablation) of the prostate with high intensity focused ultrasound (HIFU) in patients suitable for \"Active Surveillance\" (AP 68/11 of the AUO)]\nhttps://pubmed.ncbi.nlm.nih.gov/24556711/"}}